Stocks · Healthcare · Medical - Care Facilities
Hims & Hers Health, Inc. HIMS
$29.00 -1.02% Close, Oct 2, 2026 · NYSE · Market cap $6.47B
High risk
Next earnings report: Nov 9, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Diluted EPS over the last four quarters was $-0.63, down 178.3% year over year.
- Operating margin narrowed to -3.6% from 6.2% a year earlier.
- The diluted share count fell 9.7% in a year, mainly through buybacks.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 25%
- EPS growth (TTM, YoY)Bottom 12%
- FCF growth (TTM, YoY)Bottom 23%
- Revenue growth, 3-year CAGRTop 10%
- Revenue growth accelerationBottom 26%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 37%
- Gross marginBottom 50%
- Operating marginTop 46%
- Accruals (lower is better)Top 30%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 37%
- Free-cash-flow yieldTop 31%
- EBITDA / enterprise valueTop 40%
- Sales / enterprise valueTop 37%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 7%
- 6-month returnTop 19%
- 1-year return vs S&P 500Bottom 10%
- Distance from 52-week highBottom 21%
- Trend checklist (0–4)Top 20%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersBottom 5%
- Consecutive EPS beatsBottom 20%
- Share of analysts rating BuyBottom 5%
- Upside to consensus price targetBottom 19%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 15%
- Maximum drawdown, 3 yearsBottom 35%
- Beta vs S&P 500 (lower is better)Bottom 5%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 32.8% | 28.0% | ↓ |
| EPS growth (YoY) | -112.6% | -178.3% | ↓ |
| Gross margin | 76.2% | 64.7% | ↓ |
| Operating margin | 6.2% | -3.6% | ↓ |
| FCF margin | 5.9% | 3.5% | ↓ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 28.0% | 32.8% | ↓ | Top 25% |
| EPS growth (TTM, YoY) | -178.3% | -112.6% | ↓ | Bottom 12% |
| Gross margin | 64.7% | 76.2% | ↓ | Bottom 50% |
| Operating margin | -3.6% | 6.2% | ↓ | Top 46% |
| Net margin | -5.5% | 9.6% | ↓ | — |
| Free-cash-flow margin | 3.5% | 5.9% | ↓ | — |
| Return on invested capital | -3.7% | — | Top 37% | |
| Revenue growth, 3-year CAGR | 64.5% | — | Top 10% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -11.3%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 6.0%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- +5444.2 pp
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- 1.22%
- Shareholder yield
- 1.22%
- Share count change, 1 year
- -9.7%
- Share count change, 3-year CAGR
- +3.6%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 10, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 0
- Beats in the last 8 reports
- 4 of 8
- Average EPS surprise, last 4
- -100.0%
- Average 2-day reaction, last 8
- +1.3%
- Positive 20 days after report
- 3 of 8
Analysts
- Consensus price target
- $32.17
- Target vs current price
- +10.9%
- Analysts with a rating
- 20
- Share rating Buy or Strong Buy
- 35%
- Consensus rating
- Hold
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 10, 2026 | -643.1% | +0.6% | -10.9% | -12.3% | — |
| May 11, 2026 | -1676.7% | +3.1% | -11.4% | -3.9% | +12.0% |
| Feb 23, 2026 | +250.0% | -0.8% | -7.1% | +40.9% | +42.6% |
| Nov 3, 2025 | -33.3% | -2.4% | -9.7% | -17.5% | -34.3% |
| Aug 4, 2025 | -5.6% | +1.3% | -17.0% | -32.3% | -22.9% |
| May 5, 2025 | +65.4% | +2.6% | +27.3% | +39.1% | +60.5% |
| Feb 24, 2025 | +22.2% | +4.1% | -8.5% | -29.5% | +26.5% |
| Nov 4, 2024 | +433.3% | +2.0% | +15.0% | +51.5% | +83.1% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 10, 2026 | -$0.37 | -$0.05 | -643.1% | $753.2M |
| May 11, 2026 | -$0.40 | $0.03 | -1676.7% | $608.1M |
| Feb 23, 2026 | $0.07 | $0.02 | +250.0% | $617.8M |
| Nov 3, 2025 | $0.06 | $0.09 | -33.3% | $599.0M |
| Aug 4, 2025 | $0.17 | $0.18 | -5.6% | $544.8M |
| May 5, 2025 | $0.20 | $0.12 | +65.4% | $586.0M |
| Feb 24, 2025 | $0.11 | $0.09 | +22.2% | $481.1M |
| Nov 4, 2024 | $0.32 | $0.06 | +433.3% | $401.6M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| EV / Sales | 2.87× | — | — | Top 37% |
| Free-cash-flow yield | 1.39% | — | — | Top 31% |
| Earnings yield | -2.16% | — | — | Top 37% |
P/E over the past five years
Range 30.2× – 233.2× since Jun 30, 2024. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
What moved the stock over the past year
- Price return, 1 year
- -48.5%
- Earnings per share growth (TTM)
- -178.3%
- Change in P/E multiple
- -68.4%
Most of the move came from a change in the valuation multiple.
Technical state
Trend checklist
- ✓ Price above 20-day average
- ✗ Price above 50-day average
- ✓ Price above 200-day average
- ✓ 50-day average above 200-day
- ✓ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 11
- 50-day average slope (20 days)
- -7.6%
- 200-day average slope (20 days)
- -3.1%
- Distance from 50-day average
- -1.0%
- Distance from 200-day average
- +5.3%
- RSI (14)
- 49.5
- Relative volume
- 1.04×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 84.8%
- Volatility vs own 5-year history
- 69th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 2.49
- Correlation with S&P 500
- 0.35
- Current drawdown from 1-year high
- -53.8%
- Maximum drawdown, 3 years
- -78.9%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Feb 8, 2021 | May 11, 2022 | -87.3% | 317 days | 528 days (Jun 18, 2024) |
| Feb 19, 2025 | Feb 27, 2026 | -78.9% | 257 days | Not yet recovered |
| Jun 18, 2024 | Sep 6, 2024 | -44.9% | 55 days | 46 days (Nov 11, 2024) |
| Nov 11, 2024 | Nov 15, 2024 | -30.7% | 4 days | 6 days (Nov 25, 2024) |
| Dec 6, 2024 | Dec 31, 2024 | -29.4% | 16 days | 20 days (Jan 31, 2025) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $6.47B
- EPS, diluted (TTM)
- -$0.63
- Revenue (TTM)
- $2.58B
- 52-week range
- $13.74 – $65.30
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $271.9M | $526.9M | $872.0M | $1.48B | $2.35B |
| Gross profit | $204.5M | $408.7M | $714.9M | $1.17B | $1.73B |
| Operating income | -$115.0M | -$68.7M | -$29.5M | $61.9M | $105.6M |
| Net income | -$107.7M | -$65.7M | -$23.5M | $126.0M | $128.4M |
| EPS (diluted) | -$0.58 | -$0.32 | -$0.11 | $0.53 | $0.51 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $401.6M | $481.1M | $586.0M | $544.8M | $599.0M | $617.8M | $608.1M | $753.2M |
| Net income | $75.6M | $26.0M | $49.5M | $42.5M | $15.8M | $20.6M | -$92.1M | -$86.3M |
| EPS (diluted) | $0.32 | $0.11 | $0.20 | $0.17 | $0.06 | $0.08 | -$0.40 | -$0.37 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | -$34.4M | -$26.5M | $73.5M | $251.1M | $300.0M |
| Capital expenditure | -$5.0M | -$7.2M | -$26.5M | -$52.8M | -$226.0M |
| Free cash flow | -$39.4M | -$33.8M | $47.0M | $198.3M | $74.0M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $250.7M | $0 | -$2.0M | -$83.0M | -$72.5M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $841.0M
- Total assets
- $3.63B
- Total liabilities
- $3.30B
- Total debt
- $1.55B
- Net debt
- $936.4M
- Shareholders’ equity
- $324.1M
As of Jun 30, 2026 (filed Aug 10, 2026).
Short interest
- Shares sold short
- 52,920,443
- Days to cover
- 6.13
- Change vs previous report
- -3.7%
FINRA short interest, settlement date Sep 15, 2026.